Rock Springs Capital Management LP - CINCOR PHARMA INC ownership

Back to all holdings Add to watchlist

CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 106 filers reported holding CINCOR PHARMA INC in Q4 2022. The put-call ratio across all filers is 2.63 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of CINCOR PHARMA INC
ValueSharesWeighting
Q4 2022$13,722,744
-65.3%
1,116,578
-7.4%
0.33%
-67.7%
Q3 2022$39,576,000
+105.7%
1,205,856
+18.1%
1.02%
+82.5%
Q2 2022$19,239,000
+6.4%
1,021,159
-1.0%
0.56%
+23.1%
Q1 2022$18,087,000–1,031,159–0.46%–
 Download
Other shareholders
CINCOR PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,937,646$60,683,66916.31%
Sofinnova Investments, Inc. 6,073,949$74,648,8334.43%
Omega Fund Management, LLC 560,985$7,853,7902.65%
GREAT POINT PARTNERS LLC 1,019,153$12,525,3902.46%
venBio Partners LLC 383,390$4,711,8631.46%
Cheyne Capital Management (UK) LLP 67,557$830,2761.45%
SPHERA FUNDS MANAGEMENT LTD. 529,640$6,509,2761.40%
SILVERARC CAPITAL MANAGEMENT, LLC 395,382$4,859,2451.39%
Perceptive Advisors 2,576,325$31,663,0340.89%
AlphaCentric Advisors LLC 70,000$860,3000.85%
View complete list of CINCOR PHARMA INC shareholders